Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers. The strategy changed its peer group last March, moving from the Large Blend category to the Mid-Cap Blend Morningstar Category.
Copeland Dividend Growth Fund Class C CDCRX Fund Analysis
Morningstar’s Analysis CDCRX
Will CDCRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar